NZ211071A - Calciferol derivatives, ketone precursors, and calciferol derivative containing medicaments - Google Patents

Calciferol derivatives, ketone precursors, and calciferol derivative containing medicaments

Info

Publication number
NZ211071A
NZ211071A NZ211071A NZ21107185A NZ211071A NZ 211071 A NZ211071 A NZ 211071A NZ 211071 A NZ211071 A NZ 211071A NZ 21107185 A NZ21107185 A NZ 21107185A NZ 211071 A NZ211071 A NZ 211071A
Authority
NZ
New Zealand
Prior art keywords
formula
compound
methyl
calciferol
side chain
Prior art date
Application number
NZ211071A
Other languages
English (en)
Inventor
E G Baggiolini
A D Batcho
G A Truitt
M R Uskokovic
P M Wovkulich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ211071A publication Critical patent/NZ211071A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ211071A 1984-02-08 1985-02-07 Calciferol derivatives, ketone precursors, and calciferol derivative containing medicaments NZ211071A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57816084A 1984-02-08 1984-02-08
US68212584A 1984-12-17 1984-12-17

Publications (1)

Publication Number Publication Date
NZ211071A true NZ211071A (en) 1988-04-29

Family

ID=27077449

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ211071A NZ211071A (en) 1984-02-08 1985-02-07 Calciferol derivatives, ketone precursors, and calciferol derivative containing medicaments

Country Status (10)

Country Link
EP (1) EP0154185B1 (da)
JP (1) JPH0735365B2 (da)
AU (1) AU575373B2 (da)
CA (1) CA1311501C (da)
DE (1) DE3565401D1 (da)
DK (1) DK157244C (da)
IE (1) IE57917B1 (da)
IL (1) IL74264A (da)
NZ (1) NZ211071A (da)
PH (1) PH19845A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
CA2062520C (en) * 1991-03-11 1998-08-11 Hector F. Deluca Synthesis of 1-alpha-hydroxy-secosterol compounds
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5300705A (en) * 1993-03-18 1994-04-05 Hoffmann-La Roche Inc. Process for the preparation of 1α,25,26-trihydroxy-22-ene-cholecalciferol
JP4752110B2 (ja) * 2000-12-25 2011-08-17 住友化学株式会社 トリフルオロプロペニル化合物の製造法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
EP0086350A3 (de) * 1982-02-12 1984-11-28 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholesterinderivaten
NZ203251A (en) * 1982-02-12 1986-04-11 Hoffmann La Roche Pharmaceutical compositions containing 1alpha,25,26-trihydroxycholecalciferol
JPS58210017A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
WO1984000107A1 (en) * 1982-06-30 1984-01-19 Massachusetts Gen Hospital Vitamin d glycosides
DE3471928D1 (en) * 1983-01-28 1988-07-14 Hoffmann La Roche Process for the preparation of cholecalciferol derivatives

Also Published As

Publication number Publication date
EP0154185A1 (en) 1985-09-11
IL74264A (en) 1988-08-31
DK157244C (da) 1990-04-23
JPS60248664A (ja) 1985-12-09
IL74264A0 (en) 1985-05-31
EP0154185B1 (en) 1988-10-05
IE850298L (en) 1985-08-08
IE57917B1 (en) 1993-05-19
JPH0735365B2 (ja) 1995-04-19
AU575373B2 (en) 1988-07-28
AU3846985A (en) 1985-08-15
DK157244B (da) 1989-11-27
DK53785A (da) 1985-08-09
DE3565401D1 (de) 1988-11-10
PH19845A (en) 1986-07-22
DK53785D0 (da) 1985-02-06
CA1311501C (en) 1992-12-15

Similar Documents

Publication Publication Date Title
JP6087381B2 (ja) 新規なセファロタキサン誘導体の製造に用いられるカルボン酸誘導体
EP0918776B1 (en) Total synthesis of antitumor acylfulvenes
CZ297803B6 (cs) Analogy illudinu a farmaceutický prostredek
US5120722A (en) Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
EP0154185B1 (en) Calciferol derivatives
WO1989009772A1 (fr) PROCEDE STEREOSPECIFIQUE POUR LA PREPARATION DES ENANTIOMERES DE LA FURO[3,4-c]PYRIDINE, COMPOSES AINSI OBTENUS ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES COMPOSES
JP2009512662A (ja) 中間体、並びにかかる中間体を用いたエクチナサイジン５８３、５９７などのエクチナサイジン類の調製方法
Riehs et al. EPC synthesis of (+)-heptelidic acid
US5442065A (en) Synthesis of tetrahydroquinoline enediyne core analogs of dynemicin
CA1166639A (en) Pharmacologically active 4-¬2-hydroxy-4- (substituted)phenyl|naphthalen-2(1h)-ones and 2- ols, derivatives thereof and intermediates therefor
EP1904485A2 (en) Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use
US5110958A (en) Compounds, process and intermediates
EP2242502A1 (en) Synthesis of macrocyclic cancer chemotherapy agents and methods of use
CA2647655A1 (en) Novel c-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation